- Home
- REVG vs ITRM Comparison
REVG vs ITRM Comparison
Compare REVG & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REVG
- ITRM
- Stock Information
- Founded
- REVG 2008
- ITRM 2015
- Country
- REVG United States
- ITRM Ireland
- Employees
- REVG N/A
- ITRM N/A
- Industry
- REVG Auto Manufacturing
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- REVG Consumer Discretionary
- ITRM Health Care
- Exchange
- REVG Nasdaq
- ITRM Nasdaq
- Market Cap
- REVG 2.2B
- ITRM 40.0M
- IPO Year
- REVG 2017
- ITRM 2018
- Fundamental
- Price
- REVG $49.69
- ITRM $0.94
- Analyst Decision
- REVG Hold
- ITRM Strong Buy
- Analyst Count
- REVG 4
- ITRM 2
- Target Price
- REVG $41.25
- ITRM $7.00
- AVG Volume (30 Days)
- REVG 658.5K
- ITRM 534.3K
- Earning Date
- REVG 06-04-2025
- ITRM 08-13-2025
- Dividend Yield
- REVG 0.48%
- ITRM N/A
- EPS Growth
- REVG N/A
- ITRM N/A
- EPS
- REVG 1.86
- ITRM N/A
- Revenue
- REVG $2,331,500,000.00
- ITRM N/A
- Revenue This Year
- REVG $3.60
- ITRM N/A
- Revenue Next Year
- REVG $6.89
- ITRM $270.19
- P/E Ratio
- REVG $26.68
- ITRM N/A
- Revenue Growth
- REVG N/A
- ITRM N/A
- 52 Week Low
- REVG $21.54
- ITRM $0.81
- 52 Week High
- REVG $50.34
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- REVG 77.07
- ITRM 41.32
- Support Level
- REVG $48.52
- ITRM $0.91
- Resistance Level
- REVG $50.34
- ITRM $1.03
- Average True Range (ATR)
- REVG 1.19
- ITRM 0.04
- MACD
- REVG 0.15
- ITRM -0.01
- Stochastic Oscillator
- REVG 91.01
- ITRM 16.28
About REVG REV Group Inc.
REV Group Inc is a United States-based designer, manufacturer, and distributor of specialty vehicles and related aftermarket parts and services. During the first fiscal quarter of 2024, the Company formed the Specialty Vehicles Segment by combining the Fire & Emergency and Commercial segment businesses. Additionally, the Recreation segment was renamed Recreational Vehicles. As a result, the Company is now organized into two reportable segments. The company operates in the United States, Canada, and the rest of the world. Maximum of revenue is gained from Specialty Vehicles Segment.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.